3961 - 3970 of 6420 Results
Title
Year
-
OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 51Start Page: E12053End Page: E12062Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 83
- L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression2019OPENTitle: L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.022Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/294951Citation Count: 28
- Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics2016OPENTitle: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analyticsJournal Name: mHealthPublisher: AME Publishing CompanyVol: 2Issue #:Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02Best OA location URL: https://mhealth.amegroups.com/article/viewFile/10369/pdfCitation Count: 34
-
OPENTitle: Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progressionJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 3Start Page: 309End Page: 322Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00042-6Best OA location URL: https://www.nature.com/articles/s43587-021-00042-6.pdfCitation Count: 47
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950Citation Count: 0
-
OPENTitle: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task ForceJournal Name: Value in HealthPublisher: Elsevier BVVol: 26Issue #: 4Start Page: 449End Page: 460Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006Best OA location URL: http://www.valueinhealthjournal.com/article/S1098301522047805/pdfCitation Count: 19
-
OPENTitle: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European populationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00896-2Best OA location URL: https://www.nature.com/articles/s41531-025-00896-2.pdfCitation Count: 0
-
OPENTitle: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent modelJournal Name: BMC Research NotesPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13104-020-04994-7Best OA location URL: https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-020-04994-7Citation Count: 16
-
OPENTitle: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 49End Page: 59Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196Best OA location URL: https://doi.org/10.1016/j.jalz.2019.08.196Citation Count: 39
-
OPENTitle: Sequence of clinical and neurodegeneration events in Parkinson’s disease progressionJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 3Start Page: 975End Page: 988Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaa461Best OA location URL: https://academic.oup.com/brain/article-pdf/144/3/975/37036706/awaa461.pdfCitation Count: 83